Celgene logo

Celgene

Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.

3

Funding Rounds

$34.7m

Money raised

Overview

Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.

Funding

Funding series

Funding Series Analysis

The company Celgene has raised a total of $34.65m in funding over 3 rounds.

Key Insights:

  • Celgene funding round, February 2012: $15m
  • Celgene Series B round: $12.4m
  • Celgene Series A round: $7.25m
Celgene logo
Celgene funding round, February 2012 $15m
Celgene logo
Celgene Series B round $12.4m
Celgene logo
Celgene Series A round $7.25m

Subsidiaries

Celgene operates through the following subsidiaries: